Here, we demonstrated that intervention with FXR ligand, 6ECDCA significantly improves kidney injury by mediating anti-fibrosis, anti-inflammation, and anti-apoptosis processes in cisplatin-induced kidney injury. This evidence concerns the gene NR1H4 and kidney injury.